Location History:
- Ibaraki, JP (2003)
- Tsukuba, JP (2007)
- Tokyo, JP (1995 - 2012)
Company Filing History:
4 out of 329 
3 out of 417 
Years Active: 1995-2012
Title: Satoshi Hayashibe: Innovator in NMDA Receptor Antagonists
Introduction
Satoshi Hayashibe is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as NMDA receptor antagonists. With a total of 7 patents to his name, Hayashibe's work has the potential to impact the treatment of various neurological disorders.
Latest Patents
One of Hayashibe's latest patents involves a fused indane compound. This compound is designed to serve as an NMDA receptor antagonist, which has been confirmed to exhibit excellent NMDA receptor antagonistic action. The implications of this invention are profound, as it can be utilized as a prophylactic and/or therapeutic agent for conditions such as Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, intractable depression, attention deficit hyperactivity disorder, and migraines. Another notable patent is for an aminoindane derivative or its salt, which also functions as an NMDA receptor antagonist. This compound is characterized by a broader safety margin and is useful in treating or preventing similar neurological conditions.
Career Highlights
Throughout his career, Satoshi Hayashibe has worked with notable companies in the pharmaceutical industry, including Yamanouchi Pharmaceutical Company Ltd. and Astellas Pharma GmbH. His innovative research and development efforts have positioned him as a key figure in the advancement of treatments for neurological disorders.
Collaborations
Hayashibe has collaborated with esteemed colleagues such as Masamichi Okada and Hirotsune Itahana. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Satoshi Hayashibe's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a significant inventor. His work in developing NMDA receptor antagonists has the potential to transform the treatment landscape for various neurological disorders.